Tumor necrosis factor-&alpha; inhibitors and chronic hepatitis C: A comprehensive literature review

doi:10.3748/wjg.v19.i44.7867

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 19, Issue 44

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7302)

All Articles published online

The chart showing PDF series, HTML series, Tables (1-1) series.

Item

Count

PDF

608

HTML

4493

Tables (1-1)

116

Sum=5217

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1180

Download

905

Sum=2085

Nov 28, 2013 (publication date) through May 5, 2024

Times Cited of This Article

Times Cited (73)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Topic Highlight

World J Gastroenterol. Nov 28, 2013; 19(44): 7867-7873
Published online Nov 28, 2013. doi: 10.3748/wjg.v19.i44.7867

Tumor necrosis factor-α inhibitors and chronic hepatitis C: A comprehensive literature review

Maurizio Pompili, Marco Biolato, Luca Miele, Antonio Grieco

Maurizio Pompili, Marco Biolato, Luca Miele, Antonio Grieco, Department of Internal Medicine, Università Cattolica del Sacro Cuore, 8-00168 Roma, Italy

Author contributions: Pompili M and Biolato M designed the study, wrote the manuscript, and revised the final version of the article; Miele L and Grieco A contributed to the literature search and writing the manuscript.

Correspondence to: Maurizio Pompili, MD, Department of Internal Medicine, Università Cattolica del Sacro Cuore, Largo A Gemelli, 8-00168 Roma, Italy. mpompili@rm.unicatt.it

Telephone: +39-6-30154334 Fax: +39-6-35502775

Received: September 27, 2013
Revised: October 31, 2013
Accepted: November 12, 2013
Published online: November 28, 2013

Core Tip

Core tip: Our review summarizes data on patients with hepatitis C exposed to tumor necrosis factor-α (TNF-α) inhibitors, thus building a stronger safety profile than previously reported. A comprehensive paragraph on the pathway of TNF-α in hepatitis C virus (HCV) and an overview on immune-mediated damage induced by TNF-α inhibitors (cryoglobulins, autoimmune hepatitis) have been also included. Some controversies regarding the universal screening and monitoring of HCV-RNA were also addressed.